Immunoseroproteomic profiling in autoantibody to ENO1 as potential biomarker in immunodiagnosis of osteosarcoma by serological proteome analysis (SERPA) approach-Reference-Cited by-同舟云学术

Immunoseroproteomic profiling in autoantibody to ENO1 as potential biomarker in immunodiagnosis of osteosarcoma by serological proteome analysis (SERPA) approach

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Li Jitian¹²,Dai Liping¹^ORCID,Huang Manyu²,Ma Yan²^ORCID,Guo Zhiping²^ORCID,Wang Xiao¹,Li Wuyin²,Zhang Jian-Ying¹

Affiliation:

1. Department of Biological Sciences & NIH-sponsored Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX, USA

2. Laboratory of Molecular Biology, Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital)/Henan Institute of Orthopedic and Traumatology, Luoyang, Henan, China

Funder

The National Institutes on Minority Health and Health Disparities

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1966969

Reference44 articles.

1. Osteosarcoma Overview

2. Future Directions in the Treatment of Osteosarcoma

3. Current and future therapeutic approaches for osteosarcoma

4. Childhood and adolescent cancer statistics, 2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 3D-printed scaffold-based osteosarcoma model allows to investigate tumor phenotypes and pathogenesis in an in vitro bone-mimicking niche;Materials Today Bio;2022-06

2. Evaluating a Panel of Autoantibodies Against Tumor-Associated Antigens in Human Osteosarcoma;Frontiers in Genetics;2022-04-25